The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.2 - Manufacture of pharmaceutical preparations
45 jobs Number of planned job losses
Announcement Date
26 March 2012
Employment effect (start)
Foreseen end date
Description
British multinational pharmaceutical company Glaxo Smith Kline (GSK) is about to cut 45 jobs at its plant in Wavre. The company has announced the restructuring to its works council and the Renault procedure has been launched. As of March 2012, there is no indication of when the restructuring will take place.
The internal restructuring will take place at one pharmaceutical department which employs 350.
Sources
26 March 2012: La Libre
Citation
Eurofound (2012), Glaxo Smith Kline Pharmaceuticals, Internal restructuring in Belgium, factsheet number 73387, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/73387.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
